Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 12,274 | $68.36 | $839,070 | 35,028 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 12,440 | $68.36 | $850,417 | 63,959 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 11,324 | $68.21 | $772,444 | 86,255 (Indirect Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 13,056 | $68.36 | $892,528 | 61,480 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 1,144 | $68.36 | $78,204 | 41,708 (Indirect Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 6,430 | $68.36 | $439,566 | 43,316 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 34,603 | $68.34 | $2,364,904 | 891,412 (Indirect Direct) | View |
| 2026-03-16 Sale | 2026-03-18 4:11 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 12,500 | $68.79 | $859,819 | 116,332 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 4:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 8,366 | $76.67 | $641,421 | 71,292 (Indirect Direct) | View |
| 2026-01-02 Sale | 2026-01-06 4:05 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 15,565 | $80.67 | $1,255,684 | 23,393 (Direct) | View |
| 2025-12-24 Sale | 2025-12-30 4:26 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $82.51 | $495,089 | 859,741 (Indirect Direct) | View |
| 2025-12-16 Sale | 2025-12-18 4:09 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 7,397 | $80.1 | $592,500 | 38,958 (Direct) | View |
| 2025-12-15 Sale | 2025-12-17 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 22,946 | $81.26 | $1,864,678 | 128,832 (Indirect Direct) | View |
| 2025-12-16 Sale | 2025-12-17 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 2,078 | $79.5 | $165,201 | 60,800 (Indirect Direct) | View |
| 2025-09-24 Sale | 2025-09-26 4:08 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $55.37 | $332,220 | 865,741 (Indirect Direct) | View |
| 2025-09-08 Sale | 2025-09-10 5:03 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 27,116 | $57 | $1,545,612 | 153,778 (Indirect Direct) | View |
| 2025-08-11 Sale | 2025-08-13 4:32 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $50 | $300,000 | 871,741 (Indirect Direct) | View |
| 2025-06-17 Sale | 2025-06-18 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 13,608 | $40.42 | $550,035 | 92,467 (Direct) | View |
| 2025-06-16 Sale | 2025-06-17 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 1,006 | $41.08 | $41,326 | 35,600 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-15 Exercise | 2026-03-17 4:40 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 47,818 | $0 | 83,969 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:38 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 48,472 | $0 | 113,066 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:35 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 52,574 | $0 | 136,834 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:32 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 52,964 | $0 | 115,298 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:27 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 26,084 | $0 | 80,853 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:24 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 132,548 | $0 | 1,033,867 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:20 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 2,511 | $0 | 50,386 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2026-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 44,471 | $0 | 44,471 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 50,030 | $0 | 50,030 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 50,030 | $0 | 50,030 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 44,471 | $0 | 44,471 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 44,471 | $0 | 44,471 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 44,471 | $0 | 44,471 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 157,499 | $0 | 157,499 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 4:35 pm | N/A 2036-02-17 | Tarsus Pharmaceuticals Inc. | TARS | PYOTT DAVID E I Director | 9,622 | $0 | 9,622 (Direct) | View |
Ownership | 2026-02-20 4:35 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | PYOTT DAVID E I Director | 0 | $0 | 23,502 (Indirect) | View |
| 2025-12-15 Exercise | 2026-01-14 7:32 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director | 2,233 | $0 | 6,700 (Direct) | View |
| 2025-12-16 Gift | 2025-12-18 4:09 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 1,425 | $0 | 79,658 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 4:07 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 6,819 | $0 | 60,800 (Direct) | View |
| 2025-12-04 Gift | 2025-12-08 4:06 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 51,885 | $0 | 865,741 (Direct) | View |
| 2025-09-16 Gift | 2025-09-18 5:00 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 2,000 | $0 | 151,778 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-16 4:06 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 1,334 | $0 | 10,700 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 4:07 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 27,881 | $0 | 92,467 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-17 4:07 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 3,350 | $0 | 35,600 (Direct) | View |